INVASIVE ASPERGILLOSIS IN CRITICALLY ILL PATIENTS: ANALYSIS OF RISK FACTORS FOR ACQUISITION AND MORTALITY

REFERENCES

• Clancy CJ, Nguyen MH. Acute community-acquired pneumo-nia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. Chest 1998; 114: 629–34.
   PubMed Web of Science ®Google Scholar
• Karam GH, Griffin FM, Jr. Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts. Rev Infect Dis. 1986; 8: 357–63.
   PubMedGoogle Scholar
• Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic ob-structive pulmonary disease: report of eight cases and review. Clin Infect Dis. 1998; 26: 1473–5.
   PubMed Web of Science ®Google Scholar
• Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Casewell M, Fagan E, Williams R. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol. 1991; 12: 1–9.
   PubMed Web of Science ®Google Scholar
• Engelich G, Wright DG, Hartshorn KL. Acquired disorders of phagocyte function complicating medical and surgical ill-nesses. Clin Infect Dis. 2001; 33: 2040–8.
   PubMed Web of Science ®Google Scholar
• Blot S, Vandewoude K. Early detection of systemic infections. Acta Clin Belg. 2004; 59: 20–3.
   PubMed Web of Science ®Google Scholar
• Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998; 26: 781–803; quiz 804-785.
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman J. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13: 818–29.
   PubMed Web of Science ®Google Scholar
• Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an interna-tional consensus. Clin Infect Dis. 2002; 34:7–14.
   PubMed Web of Science ®Google Scholar
• Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med. 2002; 113:480–5.
   PubMed Web of Science ®Google Scholar
• Noble JS, MacKirdy FN, Donaldson SI, Howie JC. Renal and respiratory failure in Scottish ICUs. Anaesthesia 2001; 56:124–9.
   PubMed Web of Science ®Google Scholar
• Groeneveld AB, Tran DD, van der Meulen J, Nauta JJ, Thijs LG. Acute renal failure in the medical intensive care unit: pre-disposing, complicating factors and outcome. Nephron 1991; 59: 602–10.
   PubMed Web of Science ®Google Scholar
• Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and Attributable Mortality in Critically Ill Patients With Bacteremia Involving Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus. Arch Intern Med. 2002; 162: 2229–35.
   PubMed Web of Science ®Google Scholar
• Blot S, Vandewoude K, De Bacquer D, Colardyn F. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacte-ria in critically ill patients: clinical outcome and length of hos-pitalization. Clin Infect Dis. 2002; 34:1600–6.
   PubMed Web of Science ®Google Scholar
• Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect. 1996; 33: 23–32.
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Kume H, Murase S, Yamashita E, Arisawa M. Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan. J Clin Microbiol. 1999; 37: 1732–8.
   PubMed Web of Science ®Google Scholar
• Chandrasekar PH, Alangaden G, Manavathu E. Aspergillus: an increasing problem in tertiary care hospitals? Clin Infect Dis. 2000 30: 984–5.
   PubMed Web of Science ®Google Scholar
• Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis. 1998; 27: 1138–47.
   PubMed Web of Science ®Google Scholar
• Dimopoulos G, Piagnerelli M, Berré J, Eddafli B, Salmon I, Vincent J-L. Disseminated Aspergillosis in Intensive Care Patients: an Autopsy Study. J Chemother. 2003; 15: 71–75.
   PubMed Web of Science ®Google Scholar
• Temmerman W, Benoit D, Vandewoude K, Decruyenaere J, Colardyn F. Invasive aspergillosis in the ICU: incidence and characteristics. Intensive Care Med. 2000; 26:S376, abstract 638.
   PubMedGoogle Scholar
• Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis. 2002; 21:161–72.
   PubMed Web of Science ®Google Scholar
• Perfect JR, Cox GM, Lee JY, et al. The impact of culture isola-tion of Aspergillus species: a hospital-based survey of aspergil-losis. Clin Infect Dis. 2001; 33: 1824–33.
   PubMed Web of Science ®Google Scholar
• Janssen JJ, Strack van Schijndel RJ, van der Poest Clement EH, Ossenkoppele GJ, Thijs LG, Huijgens PC. Outcome of ICU treatment in invasive aspergillosis. Intensive Care Med. 1996; 22: 1315–22.
   PubMed Web of Science ®Google Scholar
• Vandewoude K, Blot S, Benoit D, Colardyn F, Vogelaers D. Invasive aspergillosis in critically ill patients: attributable mor-tality and excesses in length of ICU stay and ventilator depend-ence. J Hosp Infect. 2004; 56: 269–76.
   PubMed Web of Science ®Google Scholar